Transformative Therapies in Cancer Treatment

What is Transformative Therapies?

Transformative cancer therapies are groundbreaking treatment modalities that leverage novel biological mechanisms to improve therapeutic outcomes over standard-of-care regimens. These innovative approaches often exploit recent scientific discoveries to target cancer through distinct mechanisms.

Examples of transformative therapies include gene and viral therapies modifying genetic material, immunotherapies harnessing the immune system, targeted therapies against specific molecular drivers, and novel therapeutic platforms like antibody-drug conjugates. These cutting-edge treatments aim to overcome limitations of conventional cytotoxic chemotherapies.

NFCR's Current Early Detection & Intervention Focus

A little over 2 million new cancer cases are expected to be diagnosed in the US in 2024 – 20% of new cancer diagnoses come from cancer survivors. One of NFCR’s current focuses is to conduct more research on early cancer detection and early-stage cancer intervention and treatment. We are supporting a group of leading-edge scientists pioneering and investigating innovative approaches to stop cancers at their early stage, such as stage zero, and to detect them before new cancer happens.

Our goal is to reduce cancer incidences and increase cancer survivors. Through a focus on the detection and eradication of the first cancer cell, we can stop cancer before it starts!

NFCR IMPACTS IN EARLY DETECTION AND INTERVENTION RESEARCH

NFCR has funded research on biomarkers and imaging techniques to improve early detection of cancer, leading to advances like the discovery of altered methylation patterns in precancerous cells.
Through its public education and awareness efforts, NFCR promotes prevention behaviors like healthy eating, exercise, and recommended cancer screenings that can reduce cancer risk and incidence.
The Foundation provides funding for chemoprevention research investigating the effectiveness of natural compounds (e.g. antioxidants) and drugs to prevent cancer, furthering the development of risk-reducing options.

NFCR IMPACTS IN TRANSFORMATIVE THERAPIES RESEARCH

NFCR provides crucial funding for early-stage research into high-risk, high-reward transformative therapy concepts that may struggle to secure traditional funding.
Through its translational research initiatives, NFCR supports the development of promising transformative therapies from laboratory discoveries to clinical applications.
NFCR facilitates collaborations between researchers, clinicians, and industry partners to accelerate the development and testing of transformative therapies.

Donate to Support Transformative Therapies Research and Beyond